Medacta Receives FDA Clearance for the Lateralized Glenosphere

Medacta was granted FDA 510(k) clearance to market its Lateralized Glenosphere. This implant, which received CE Mark approval in 2019, grows the company's offering for shoulder arthroplasty, including options for reverse shoulder replacement.

The implant features a more lateralized center of rotation vs. the company's standard...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us